Answer
It may be considered after an individual specialist benefit–risk assessment, but human evidence remains limited.
Sources for this answer
- Ultomiris 300 mg/3 mL and 1100 mg/11 mL PLGB 31187/0007emc · SmPC Current selected SmPC · Version 11
- PubMedPubMed · Reputable Web